AlphaMaven AlphaMaven

TPG launches Arcura Medical Properties - Institutional Real Estate, Inc.

Reported by IREI
Jul 2, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • TPG Real Estate completed a €400 million acquisition of a German and Dutch medical outpatient properties portfolio from Vital Infrastructure Property Trust (formerly Northwest Healthcare Properties REIT), formally launching Arcura Medical Properties as a dedicated European healthcare real estate platform on July 1, 2026.
  • • Arcura's initial portfolio comprises 30 properties spanning more than 180,000 square meters across key markets including Berlin, Hamburg, and The Randstad, serving over 400 healthcare tenants with a focus on medical outpatient buildings (MOBs) and outpatient clinical infrastructure.
  • • Simon Betty, formerly leading Vital Infrastructure Property Trust's Europe organization, appointed as CEO with over two decades of real estate investment and leadership experience; will oversee established local executive teams managing asset management, leasing, and growth initiatives.
  • • Platform positioned for disciplined, long-term growth in core European markets through standards-led property management, targeted capital investment, and tenant experience optimization, targeting regions with structural demand tailwinds for medical real estate.
Summary
TPG Real Estate announced the launch of Arcura Medical Properties on July 1, 2026, following completion of its approximately €400 million acquisition of a premier German and Dutch medical outpatient properties portfolio. The transaction, which acquired the portfolio from Vital Infrastructure Property Trust (formerly Northwest Healthcare Properties REIT), establishes Arcura as a purpose-built European healthcare real estate platform designed to capitalize on structural demand growth for clinical infrastructure across continental Europe.

The platform's initial asset base consists of 30 properties totaling more than 180,000 square meters, strategically positioned across high-demand regions including Berlin, Hamburg, and The Randstad. These properties serve over 400 healthcare tenants and specialize in medical outpatient buildings (MOBs) and outpatient clinical infrastructure—a segment experiencing secular tailwinds driven by demographic aging, healthcare decentralization trends, and rising demand for outpatient care facilities. The portfolio's geographic concentration in Germany and the Netherlands provides exposure to two of Western Europe's most developed and stable healthcare real estate markets.

Simon Betty, who previously led Vital Infrastructure Property Trust's European operations, has been appointed Chief Executive Officer of Arcura. Betty brings more than two decades of real estate investment and leadership expertise across global markets and will oversee an established local management team responsible for asset management, leasing, and growth strategy execution. The appointment signals continuity in operational leadership while establishing Arcura as an independent, specialized platform under TPG's Real Estate Partners division.

Arcura's operational strategy emphasizes standards-led asset management, targeted capital investment in existing holdings, and disciplined pursuit of growth opportunities in core European markets. The platform will focus on delivering premier tenant experiences and optimizing clinical infrastructure to support healthcare operators' core mission. This positioning aligns with TPG Real Estate's broader institutional capital deployment strategy and reflects the firm's focus on long-term, defensible real estate assets with predictable cash flows and structural growth drivers in essential service sectors.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

IREI TPG launches Arcura Medical Properties - Institutional Real Estate, Inc.